What is the Y-tunnus number of Biomendex Oy?

Biomendex Oy is registered with PRH / YTJ under Y-tunnus 2946392-2.

What is the revenue of Biomendex Oy?

Biomendex Oy reported revenue of EUR 42K in 2024.

Pasi Erik Kankaanpää is the CEO of Biomendex Oy, in role since 2023.

Tomi Juhani Numminen chairs the board of Biomendex Oy, in role since 2025.

Biomendex Oy's registered address is Korkeakoulunkatu 1.

OYActive

Y-tunnus 2946392-2Korkeakoulunkatu 1, 33720 TampereManufacture of medical and dental instruments and supplies· NACE 3250Est. 2018 · 7 years old— employees

Actively employed in the business

Name	Role	Member since
Current (3)
SM Saila Maria Vartia Deputy auditor	Deputy auditor	2025
MV Matti Viljami Valpas Audit	Audit	2025
PE Pasi Erik Kankaanpää Chief Executive Officer	Chief Executive Officer	2023
Former (3)
KJ Kaarlo Johannes Paakinaho Chief Executive Officer	Chief Executive Officer	2018 – 2022
HI Heidi Irene Hinkka Confidential Clerk	Confidential Clerk	2018 – 2020
PK Pekka Kalevi Johannes Hiltunen Audit	Audit	2020 – 2024

Non-executive oversight

Name	Role	Member since
Current (6)
OA Olli Akseli Gestranius Board of Directors	Board of Directors	2025
TJ Tomi Juhani Numminen Chairperson	Chairperson	2025
RG Robert Gustav Ashorn Board of Directors	Board of Directors	2023
KJ Kalevi Johannes Heinonen Board of Directors	Board of Directors	2023
AM Antero Markku-Ilmari Salo Board of Directors	Board of Directors	2020
AT Arto Tapio Siik Board of Directors	Board of Directors	2024
Former (7)
MJ Mikko Jukka Manninen Board of Directors	Board of Directors	2018 – 2022
AH Anna-Maria Henell Board of Directors	Board of Directors	2023 – 2024
TS Teemu Sakari Sipilä Board of Directors	Board of Directors	2022 – 2023
VE Veli-Matti Ehder-Gahm Board of Directors	Board of Directors	2022 – 2023
RG Ralph Gustav Ilmari Ashorn Board of Directors	Board of Directors	2021 – 2023
KE Kaisla Elina Lahdensuo Board of Directors	Board of Directors	2023 – 2025
MJ Mikko Juhani Latvala Board of Directors	Board of Directors	2020 – 2023

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.